# Armata Pharmaceuticals, Inc.: Form 8-K, filed Jan 13, 2026

- Company: [Armata Pharmaceuticals, Inc.](/companies/armp.md) (CIK 921114)
- Form: 8-K
- Filed: 2026-01-13
- Accepted by EDGAR: Jan 13, 2026, 07:10 ET
- Period: 2026-01-13
- Accession: 0001104659-26-003076
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921114/000110465926003076/tm262898d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921114/000110465926003076/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921114/000110465926003076/tm262898d1_8k.htm

Filed Jan 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-003076. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.